BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 6690710)

  • 1. Characterization of enhancer elements in the long terminal repeat of Moloney murine sarcoma virus.
    Laimins LA; Gruss P; Pozzatti R; Khoury G
    J Virol; 1984 Jan; 49(1):183-9. PubMed ID: 6690710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct segments within the enhancer region collaborate to specify the type of leukemia induced by nondefective Friend and Moloney viruses.
    Golemis E; Li Y; Fredrickson TN; Hartley JW; Hopkins N
    J Virol; 1989 Jan; 63(1):328-37. PubMed ID: 2783259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host-specific activation of transcription by tandem repeats from simian virus 40 and Moloney murine sarcoma virus.
    Laimins LA; Khoury G; Gorman C; Howard B; Gruss P
    Proc Natl Acad Sci U S A; 1982 Nov; 79(21):6453-7. PubMed ID: 6292901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleotide sequences of integrated Moloney sarcoma provirus long terminal repeats and their host and viral junctions.
    Dhar R; McClements WL; Enquist LW; Vande Woude GF
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):3937-41. PubMed ID: 6254003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long terminal repeat of Moloney sarcoma provirus.
    McClements WL; Dhar R; Blair DG; Enquist L; Oskarsson M; Vande Woude GF
    Cold Spring Harb Symp Quant Biol; 1981; 45 Pt 2():699-705. PubMed ID: 6266761
    [No Abstract]   [Full Text] [Related]  

  • 6. Sequences responsible for erythroid and lymphoid leukemia in the long terminal repeats of Friend-mink cell focus-forming and Moloney murine leukemia viruses.
    Ishimoto A; Takimoto M; Adachi A; Kakuyama M; Kato S; Kakimi K; Fukuoka K; Ogiu T; Matsuyama M
    J Virol; 1987 Jun; 61(6):1861-6. PubMed ID: 3033317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two blocks in Moloney murine leukemia virus expression in undifferentiated F9 embryonal carcinoma cells as determined by transient expression assays.
    Feuer G; Taketo M; Hanecak RC; Fan H
    J Virol; 1989 May; 63(5):2317-24. PubMed ID: 2704078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease specificity of nondefective Friend and Moloney murine leukemia viruses is controlled by a small number of nucleotides.
    Li Y; Golemis E; Hartley JW; Hopkins N
    J Virol; 1987 Mar; 61(3):693-700. PubMed ID: 3468264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moloney murine sarcoma proviral DNA is a transcriptional unit.
    Benz EW; Wydro RM; Nadal-Ginard B; Dina D
    Nature; 1980 Dec; 288(5792):665-9. PubMed ID: 6256637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the transcriptional properties of the Friend and Moloney retrovirus long terminal repeats: importance of tandem duplications and of the core enhancer sequence.
    Clark SP; Kaufhold R; Chan A; Mak TW
    Virology; 1985 Jul; 144(2):481-94. PubMed ID: 4060594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delineation of transcriptional control signals within the Moloney murine sarcoma virus long terminal repeat.
    Graves BJ; Eisenman RN; McKnight SL
    Mol Cell Biol; 1985 Aug; 5(8):1948-58. PubMed ID: 3018539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of glucocorticoid-responsive Moloney murine leukemia virus by insertion of regulatory sequences from murine mammary tumor virus into the long terminal repeat.
    Overhauser J; Fan H
    J Virol; 1985 Apr; 54(1):133-44. PubMed ID: 2983110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of substitution of simian virus 40 enhancer sequences into the Moloney murine leukemia virus (M-MuLV) long terminal repeat yields infectious M-MuLV with altered biological properties.
    Hanecak R; Pattengale PK; Fan H
    J Virol; 1988 Jul; 62(7):2427-36. PubMed ID: 2836623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete nucleotide sequence and organization of the Moloney murine sarcoma virus genome.
    Reddy EP; Smith MJ; Aaronson SA
    Science; 1981 Oct; 214(4519):445-50. PubMed ID: 6170110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point mutations in the Moloney murine leukemia virus enhancer identify a lymphoid-specific viral core motif and 1,3-phorbol myristate acetate-inducible element.
    Speck NA; Renjifo B; Hopkins N
    J Virol; 1990 Feb; 64(2):543-50. PubMed ID: 2104942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substitution of murine transthyretin (prealbumin) regulatory sequences into the Moloney murine leukemia virus long terminal repeat yields infectious virus with altered biological properties.
    Feuer G; Fan H
    J Virol; 1990 Dec; 64(12):6130-40. PubMed ID: 2173784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleotide sequence analysis of the long terminal repeat of integrated simian sarcoma virus: evolutionary relationship with other mammalian retroviral long terminal repeats.
    Devare SG; Reddy EP; Law JD; Aaronson SA
    J Virol; 1982 Jun; 42(3):1108-13. PubMed ID: 6284990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rearrangements and insertions in the Moloney murine leukemia virus long terminal repeat alter biological properties in vivo and in vitro.
    Fan H; Mittal S; Chute H; Chao E; Pattengale PK
    J Virol; 1986 Oct; 60(1):204-14. PubMed ID: 3747027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Envelope gene and long terminal repeat determine the different biological properties of Rauscher, Friend, and Moloney mink cell focus-inducing viruses.
    Vogt M; Haggblom C; Swift S; Haas M
    J Virol; 1985 Jul; 55(1):184-92. PubMed ID: 4009793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Important role of the long terminal repeat of the helper Moloney murine leukemia virus in Abelson virus-induced lymphoma.
    Savard P; DesGroseillers L; Rassart E; Poirier Y; Jolicoeur P
    J Virol; 1987 Oct; 61(10):3266-75. PubMed ID: 3041046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.